InvestorsHub Logo
Followers 20
Posts 1059
Boards Moderated 0
Alias Born 04/01/2013

Re: dmiller post# 194115

Thursday, 05/30/2019 9:25:06 AM

Thursday, May 30, 2019 9:25:06 AM

Post# of 429521
What's anytime soon? Between now and Within 1 year after FDA approval is the timeline where BO makes sense, after that only makes sense if they poorly launched new indication. I would guess there are some nice stock options in her future, including change of control, she'd be crazy to take this job without that.

A company I worked for hired a new CEO, 6 months later the company was put up for sale, new CEO had huge bonus if company was sold and it was. In hindsight He was hired solely to prep the company for sale, only the owners were aware, everyone else thought it was due to the massive growth we were experiencing and needed and experienced guy to take the reigns forward.

The description below sounds like something useful when selling the company since her main goal is to deal with key stakeholders. Was there a big clamoring for GIA launch to communicate with key stakeholders to increase sales? They are clearly trying to increase institutional investment, which they should, but also a higher stock price gives them more leverage in a deal and less pressure from shareholders to settle for less, especially if you communicate to these key stakeholders how valuable the company is.

"she is charged with advancing and implementing an integrated, progressive corporate communications strategy designed to educate key stakeholders about the company and its lead product, Vascepa®."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News